CD4 and COVID-19: Nine out of the ten combinations that contributed most to the variability fell on the negative axis of PC1, and included TRAV9-2 × TRAJ30 and TRAV26-1 × TRAJ39, which both showed increased proportional usage in the COVID-19 CD4 repertoires compared to healthy controls (Fig. 6B).